Healthcare - Biotechnology - NASDAQ - US
$ 1.85
-8.19 %
$ 8.48 M
Market Cap
-0.38
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
104.85%
EBIT
Estimate
7.84%
Net Income
Estimate
40.46%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioCardia, Inc.
BCDA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BCDA
EBIT FORECAST
EBIT Forecast Chart BCDA
NET INCOME FORECAST
Net Income Chart BCDA